James H. Reamer

Array ( [id] => 6017103 [patent_doc_number] => 20020103219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Stable viscous liquid formulations of amlexanox for the prevention and treatment of mucosal diseases and disorders' [patent_app_type] => new [patent_app_number] => 09/971562 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13074 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103219.pdf [firstpage_image] =>[orig_patent_app_number] => 09971562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228853 [patent_doc_number] => 06696483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => 'Inhibitors of angiogenesis and tumor growth for local and systemic administration' [patent_app_type] => B2 [patent_app_number] => 09/971062 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9163 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696483.pdf [firstpage_image] =>[orig_patent_app_number] => 09971062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440425 [patent_doc_number] => 06495590 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations' [patent_app_type] => B1 [patent_app_number] => 09/857432 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 5316 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495590.pdf [firstpage_image] =>[orig_patent_app_number] => 09857432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818262 [patent_doc_number] => 20030069220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'METHOD FOR MASS MEDICATION IN BIOLOGICAL ATTACKS' [patent_app_type] => new [patent_app_number] => 09/963741 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4508 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069220.pdf [firstpage_image] =>[orig_patent_app_number] => 09963741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1394348 [patent_doc_number] => 06545057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-08 [patent_title] => 'Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics' [patent_app_type] => B2 [patent_app_number] => 09/965138 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 7969 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/545/06545057.pdf [firstpage_image] =>[orig_patent_app_number] => 09965138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595322 [patent_doc_number] => 06384054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients' [patent_app_type] => B1 [patent_app_number] => 09/956003 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4633 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384054.pdf [firstpage_image] =>[orig_patent_app_number] => 09956003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720669 [patent_doc_number] => 20030054357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Methods and compositions for inhibiting the proliferation of prostate cancer cells' [patent_app_type] => new [patent_app_number] => 09/957359 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6915 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054357.pdf [firstpage_image] =>[orig_patent_app_number] => 09957359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033733 [patent_doc_number] => 20020019432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds' [patent_app_type] => new [patent_app_number] => 09/956661 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3050 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019432.pdf [firstpage_image] =>[orig_patent_app_number] => 09956661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454009 [patent_doc_number] => 06462051 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Composition for reducing mental fatigue, composition for maintaining and enhancing concentration, and composition for maintaining and enhancing mental vigor' [patent_app_type] => B1 [patent_app_number] => 09/951673 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4068 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462051.pdf [firstpage_image] =>[orig_patent_app_number] => 09951673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533830 [patent_doc_number] => 06488960 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Corticosteroid formulation' [patent_app_type] => B1 [patent_app_number] => 09/936586 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2700 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/488/06488960.pdf [firstpage_image] =>[orig_patent_app_number] => 09936586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017275 [patent_doc_number] => 20020103254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Paclitaxel formulation' [patent_app_type] => new [patent_app_number] => 09/948133 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7548 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103254.pdf [firstpage_image] =>[orig_patent_app_number] => 09948133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1364129 [patent_doc_number] => 06569904 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Agent for lowering endothelin levels' [patent_app_type] => B1 [patent_app_number] => 09/857560 [patent_app_country] => US [patent_app_date] => 2001-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1553 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569904.pdf [firstpage_image] =>[orig_patent_app_number] => 09857560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225362 [patent_doc_number] => 20020004498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction' [patent_app_type] => new [patent_app_number] => 09/938417 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8882 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004498.pdf [firstpage_image] =>[orig_patent_app_number] => 09938417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1347544 [patent_doc_number] => 06583127 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Use of etherlysophospholipids as antiinflammatory agents' [patent_app_type] => B1 [patent_app_number] => 09/868571 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8444 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583127.pdf [firstpage_image] =>[orig_patent_app_number] => 09868571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000721 [patent_doc_number] => 20020028850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Treating chronic uremic patients undergoing periodical dialysis' [patent_app_type] => new [patent_app_number] => 09/928504 [patent_app_country] => US [patent_app_date] => 2001-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2634 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028850.pdf [firstpage_image] =>[orig_patent_app_number] => 09928504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999370 [patent_doc_number] => 20020028250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Carbon-substituted diketopiperazine delivery systems' [patent_app_type] => new [patent_app_number] => 09/929530 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5888 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028250.pdf [firstpage_image] =>[orig_patent_app_number] => 09929530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898346 [patent_doc_number] => 20010046511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Water soluble film for oral administration with instant wettability' [patent_app_type] => new [patent_app_number] => 09/927327 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2441 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20010046511.pdf [firstpage_image] =>[orig_patent_app_number] => 09927327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1369919 [patent_doc_number] => 06566399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-20 [patent_title] => 'Inhibitor of replicative senescence of human keratinocytes containing retinoic acid as active ingredients' [patent_app_type] => B2 [patent_app_number] => 09/922070 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 7150 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566399.pdf [firstpage_image] =>[orig_patent_app_number] => 09922070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380826 [patent_doc_number] => 06555543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-29 [patent_title] => 'Method of using diketopiperazines and composition containing them' [patent_app_type] => B2 [patent_app_number] => 09/922234 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6819 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555543.pdf [firstpage_image] =>[orig_patent_app_number] => 09922234 [rel_patent_id] =>[rel_patent_doc_number] =>)